This phenomenon is likely due to the fact that EPO ameliorated parasite-induced anemia, reduced TNF-α and IFN-γ production, and decreased neuronal apoptosis, representing a potential therapeutic benefit in cerebral malaria [18]. The gene discussed is EPO; the disease is anemia (phenotype).